Figure 1.
Rosiglitazone treatment reduced inflammatory cytokine secretion in first trimester human placental explant cultures. Cytokine secretion by first trimester human placental explants at 24 hrs of LPS + Rosiglitazone treatment was measured by ELISA. Rosiglitazone treatment significantly downregulated the LPS induced secretion of inflammatory cytokines (A) TNF-α, (B) RANTES, (C) IL-8, (D) IL-1 β and (E) IL-10. n ≥ 12, For analysis data was normalized to tissue weight and PBS treated control to account for tissue to tissue variations. ‘*’ indicates significance at p < 0.05 when compared to the LPS treated group, ‘#’ indicates significance at p < 0.05 when compared to the PBS control group. Dotted line indicates levels in controls.